PDT Partners’s Audentes Therapeutics, Inc BOLD Stock Holding History

PDT Partners’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-40,308	Closed	-$2.41M	–	928
2019 Q4	$2.41M	Sell	40,308 -19,702	-33%	-$739K	0.15%	177
2019 Q3	$1.69M	Buy	60,010 +10	+0%	+$341	0.1%	224
2019 Q2	$2.27M	Buy	+60,000	New	+$2.31M	0.13%	170

PDT Partners's BOLD Position: Q1 2020 in Review

PDT Partners sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 40,308 shares — an estimated $2.41M sold.

PDT Partners first reported a position in BOLD in Q2 2019 and held it in 3 quarters. The position peaked at $2.41M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

PDT Partners reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
PDT Partners sold 40,308 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $2.41M.
PDT Partners first reported a position in Audentes Therapeutics, Inc in Q2 2019 and held it in 3 quarters.
PDT Partners's Audentes Therapeutics, Inc position peaked at $2.41M in Q4 2019.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on PDT Partners's 13F filing for Q1 2020, filed 15 May 2020.